drugset / Trial / NCT02052024
Myobloc Atrophy Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The present pilot study is designed to assess the extent to which BOTOX and MYOBLOC cause muscle atrophy in spastic patients. The primary objective is to assess whether there is statistically significant difference in muscle atrophy between the two groups over a one year period.
Timeline
- Start
- 2014-05
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum Toxin Type B | Unknown | 5000 iu | — |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 100 iu | — |